Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes
- 6 June 2013
- journal article
- Published by Elsevier BV in Leukemia Research
- Vol. 37 (9), 998-1003
- https://doi.org/10.1016/j.leukres.2013.05.013
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMSJournal of Clinical Oncology, 2010
- Evaluating the Older Patient with Cancer: Understanding Frailty and the Geriatric AssessmentCA: A Cancer Journal for Clinicians, 2010
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemiaBritish Journal of Haematology, 2009
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia RegistryBlood, 2009
- Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemiaCancer, 2007
- The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.British Journal of Haematology, 2007
- Impairment in functional status and survival in patients with acute myeloid leukaemiaZeitschrift für Krebsforschung und Klinische Onkologie, 2006
- Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:Cancer, 2006
- Developing a cancer‐specific geriatric assessmentCancer, 2005